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Abstract
Virtually all T cell development and functions depend on its antigen receptor. The T cell receptor (TCR) is a multi-protein
complex, comprised of a ligand binding module and a signal transmission module. The signal transmission module includes
proteins from CD3 family (CD3e, CD3d, CD3c) as well as the f chain protein. The CD3 proteins have a short extracellular stalk
connecting their Ig-like domains to their transmembrane regions. These stalks contain a highly evolutionarily conserved
CXXC motif, whose function is unknown. To understand the function of these two conserved cysteines, we generated mice
that lacked endogenous CD3e but expressed a transgenic CD3e molecule in which these cysteines were mutated to serines.
Our results show that the mutated CD3e could incorporate into the TCR complex and rescue surface TCR expression in CD3e
null mice. In the CD3e mutant mice, all stages of T cell development and activation that are TCR-dependent were impaired,
but not eliminated, including activation of mature naı ¨ve T cells with the MHCII presented superantigen, staphylococcal
enterotoxin B, or with a strong TCR cross-linking antibody specific for either TCR-Cb or CD3e. These results argue against a
simple aggregation model for TCR signaling and suggest that the stalks of the CD3 proteins may be critical in transmitting
part of the activation signal directly through the membrane.
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Introduction
The vertebrate immune system is an evolutionarily selected,
highly developed defense system that includes an innate
component that can be traced back to unicellular organisms and
an adaptive or antigen-specific immune response unique to
vertebrates. The ability of the antigen-specific cells of the adaptive
response to expand and give rise to immune memory can rid the
body of infection and afford life-long resistance to re-infection. A
major component of the adaptive immune system is the set of T
cells that bear ab antigen receptors (TCRs). Virtually all aspects of
the development and function of these T cells involve signaling
cascades initiated from their TCR complexes. These include the
initial expansion of thymic TCRb
+ pre-T cells, subsequent self-
MHC driven thymic positive and negative selection, self-MHC
dependent peripheral homeostasis, and of course, the response of
mature T cells to MHC presented foreign antigens.
The ab TCR complex is composed of two functionally different
modules: one for ligand binding and one for signal transmission.
The ligand-binding module is composed of two variable
polypeptide chains, TCRa and b, which form a covalently linked
heterodimer and are responsible for the ligand specificity of the
TCR. The signal-transmission module of the TCR complex,
however, is composed of invariant polypeptide chains, including
CD3e, CD3c, CD3d, and f. Among them, CD3e, CD3c, and
CD3d form non-covalently linked CD3ec and CD3ed heterodi-
mers, whereas f forms a covalently linked ff homodimer (reviewed
in [1]). Surface expression of the TCR complex requires a fully
assembled set of the complex subunits (reviewed in [2]). Assembly
begins with the formation, in the endoplasmic reticulum, of
CD3ed and CD3ec heterodimers [3]. These then associate with
TCRa and TCRb, respectively, to generate intermediate
complexes [3,4]. The ff homodimer is the last subunit to join,
and upon its incorporation, the whole TCR complex is
transported to the plasma membrane [5,6].
While the pre-TCR is thought to signal constitutively (reviewed
in [7]), at all subsequent developmental stages, engagement of the
TCR by an MHC ligand is required for signaling. There is still no
consensus on the details of how this signaling is initiated. Some
evidence supports a mechanism in which ligand dependent TCR
aggregation allows kinases associated with the cytoplasmic tails of
CD3 and co-receptors to cross-phosphorylate their targets [8–11].
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engaged, can directly transmit a signal through the membrane,
which open sites in the cytoplasmic regions of the CD3 molecules
that allow binding of other proteins involved in signal propagation
[12–17]. These two ideas are not mutually exclusive [18,19].
A strikingly evolutionarily conserved feature of the CD3 c, d,
and e molecules is a pair of cysteines in the short ‘‘stalk’’
connecting their N-terminal extracellular Ig-like domains to their
transmembrane regions (Figure 1A). Intermolecular disulfide
bonds among these proteins have not usually been seen.
Therefore, the chemical status and conserved function of these
cysteines in vivo are still under debate, although many favor a
structural role via a short intrachain disulfide [20–23]. In this
study, we compared mice that expressed wild-type (wt) CD3e to
those in which the two cysteines in the CD3e stalk were replaced
with serines. We found that abTCR surface expression on
CD4
+CD8
+ (DP) thymocytes and naı ¨ve peripheral T cells were
equivalent in the CD3e wt and mutant transgenic mice. However,
the mutation caused a profound bottleneck in all TCR dependent
processes in T cell development and compromised in the signaling
function of the TCR in the naı ¨ve peripheral T cells. Our data
suggest that TCR aggregation is not sufficient for complete TCR
activation and that the conserved CD3 cysteines may play a direct
structural role in transmitting the signal that the TCR has engaged
ligand across the plasma membrane to the cell interior.
Results
Transgenic Mice with T Cells Bearing wt or Mutated CD3e
Our purpose was to compare the development and activation of
T cells whose TCR complexes contained either CD3e whose
cysteines in the stalk region were not mutated (tge
WT) or CD3e
with cysteines mutated to serines (tge
Mut). As described in
Figure 1B and the Materials and Methods, we created transgenic
mice bearing constructs encoding e
WT or e
Mut expressed under
control of the human CD2 enhancer/promoter. These transgenes
were bred into CD3e null mice (cd3e
2/2) so that they would be
the only sources of CD3e for the TCR complex.
Similar Expression of the abTCR Complex on tge
WT and
tge
Mut T Cells
Initial characterization of the backcrossed transgenic mice
confirmed the functionality of our constructs, showing that both
tge
WT and tge
Mut could restore the appearance of peripheral T
cells in mice lacking endogenous CD3e. Backcrossed mice
expressing the highest surface level of TCR on peripheral T cells
were selected for continued breeding and a more detailed analysis.
Since previous in vitro experiments had suggested that mutation of
the CD3e CXXC motif could affect the ability of CD3e to
assemble into a complete TCR complex [23], we carefully
examined the tge
WT and tge
Mut mice for the surface level of the
abTCR on various subpopulations of T cells. The results are
shown in Table 1. There was no difference in abTCR expression
on the DP thymocytes comparing the tge
WT and tge
Mut mice.
There was some reduction (,25%–50%) in abTCR expression on
total mature peripheral T cells in the tge
Mut mice compared to the
tge
WT mice, especially on CD4
+ T cells. Since there was virtually
no difference when we examined only peripheral T cells with a
Figure 1. Two cysteines in the stalk region of CD3e are highly
conserved and form a CXXC motif. (A) Protein sequences of CD3e
from different species are aligned using the Clustal W program (http://
www.ebi.ac.uk/clustalw/). The hypothetical boundaries of the stalk
region are defined based on the mouse CD3e protein. The two
conserved cysteines in the stalk region are colored red and marked with
the arrowheads. (B) A schematic view of constructed CD3e proteins.
Both of the non-mutated (e
WT) and C-to-S mutated (e
Mut) murine CD3e
primary sequences have a c-Myc and flash tag sequence on each end.
cDNA fragments encoding these sequences were cloned into a human
CD2 minigene cassette and subsequently generated transgenic mice
were bred to endogenous cd3e null background (see Materials and
Methods for details).
doi:10.1371/journal.pbio.1000253.g001
Author Summary
The T cells of the immune system have surface receptors
that detect unique features (called antigens) of foreign
invaders such as viruses, bacteria and toxins. An encounter
between an antigen and the T cell receptor sets off a chain
of events that activates the T cell to proliferate and thus
call to action the various arms of the immune response
that ultimately eliminate the invader. A set of proteins,
called CD3, associates with the T cell receptor, spanning
the cell membrane. Their function is to deliver a signal to
the inside of T cell that its receptor has encountered
antigen on the outside of the cell. Two general ideas have
been proposed to explain how the CD3 proteins
accomplish this: That the engagement of the T cell
receptor outside the cell directly causes a change in
conformation in the intracellular portion of the associated
CD3 proteins that is recognized by the intracellular
signaling machinery; and that engagement of the T cell
receptor causes clustering of multiple receptor and CD3
proteins such that interactions among the cytoplasmic
portions of the many CD3 proteins now attract other
proteins to start the chain of intercellular signaling. These
two ideas are not mutually exclusive. We show here that
mutations in a highly conserved extracellular portion of
one of the CD3 proteins can impair the transmission of the
activation signal without preventing receptor clustering.
These results suggest that direct transmission of a
conformational change across the membrane may consti-
tute part of the CD3-mediated activation signal.
CD3e Conserved Cysteines Control TCR Signaling
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level to the large proportion of the T cells that homeostatically
expanded in the tge
Mut mice, which obtained a memory-like
phenotype (see below).
In our experiments tge
Mut transgenic mice were compared not
only to tge
WT transgenic mice but also to normal C57BL/6 mice
and to the endogenous CD3e heterozygous littermates of the two
transgenic lines: tge
WT cd3e
+/2 and tge
Mut cd3e
+/2. At any stage
of T cell development, we found no significant phenotypic
differences between the tge
WT mice and any of the other control
mice containing at least one functional copy of the endogenous
CD3e gene, despite the fact that the TCR level on tge
WT
peripheral T cell was about 50% lower than that on the normal
C57BL/6 T cells (Table 1). These results indicated that the
presence of a wt CD3e molecule in any form was sufficient for
normal T cell development and function. Therefore, for simplicity
of presentation, in most of the experiments presented below, we
combined the data for the four types of positive control mice. The
actual numbers of the different types of control mice for any
particular experiment are listed in the figure legends.
Transgenic tge
Mut Mice Have Defects in T Cell
Development in the Thymus
To study the potential effects of the e
Mut on the development of
T cells, we first looked at the cellularity in the relevant organs, that
is, thymus, spleen, and lymph nodes. As shown in Figure 2A, the
tge
Mut thymuses had only about 4% of the number of cells present
in the control thymuses. This indicated a bottleneck in T cell
development. CD3e is required for thymic T cell development and
CD3e null mice do not have T cells beyond the triple negative
stage (CD4
2CD8
2CD44
2CD25
+) because of the lack of pre-TCR
signals [24,25]. Thus, we suspected that mutating the conserved
cysteines in the CD3e stalk might also affect T cell development
beginning at an early stage.
To test this hypothesis, we examined the number of thymocytes
at various CD4
2CD8
2 (DN) stages. As shown in Figure 2B, the
thymocytes from control mice increased in number from the DN1
to DN4 stage. Those from CD3e null mice, however, were blocked
at the DN3 stage. The poor transition of tge
Mut thymocytes from
the DN3 to DN4 stage suggested a defect in pre-TCR signals. This
bottleneck at the DN3 stage was not as drastic for the tge
Mut mice
as it was for CD3e null mice. The block at DN3 is nearly complete
for CD3e null thymocytes since virtually no cells make it to the
subsequent DP or CD4
+ or CD8
+ ( single positive, SP) stages [24].
However, while the number of DP and SP thymocytes was greatly
reduced in the tge
Mut compared to control mice, a significant
number of tge
Mut thymocytes were present at the DP stage as well
as at the SP stages (Figure 2C).
The surface phenotype of the tge
Mut DP and SP thymocytes
indicated there was also a bottleneck in the TCR-driven DP to SP
transition. For example, up-regulation of CD5 expression on DP
thymocytes is thought to be an indicator of the intensity of
interactions between TCRs and self MHC-peptides during
selection [26]. As shown in Figure 2D, nearly all of the DP cells
in the control mice had elevated expression of CD5. On the other
hand, significantly fewer DP cells in the tge
Mut mice had up-
regulated CD5 expression. This indicated that fewer tge
Mut DP
cells received sufficient signals through the interaction between
their TCRs and self MHC-peptides.
CD69 has been reported to be transiently expressed on
thymocytes that are undergoing or have just finished the process
of TCR-mediated positive selection [27–29]. Thus, its expression
on SP cells is a useful marker for recently selected cells. As shown
in Figure 2E, CD8
+ SP and, more markedly, CD4
+ SP thymocytes
from tge
Mut mice had significantly fewer cells that were CD69
hi
than their counterparts in control mice. These results, coupled
with the CD5 data, indicated that positive selection in the mutant
mice was impaired.
Thus, mutation of the conserved cysteines in the CD3e stalk
region had a profound impact on thymocyte development. It not
only reduced output of cells during the DN3 to DN4 transition,
indicating a defect in pre-TCR signals, but also introduced a
defect in TCR-mediated selection during the DP and SP stages.
These results explained the reduced cellularity in the tge
Mut
thymuses and predicted a much reduced rate of thymic output to
the periphery.
Thymic Output Is Reduced and Many Peripheral T Cells
Homeostatically Proliferate in tge
Mut Mice
In the spleen, the tge
Mut mice had fewer CD4
+ and CD8
+ T
cells than all the wt controls (Figure 3A), but the extent of the
decrease (about 4-fold less for the CD4
+ and 2-fold less for the
CD8
+ T cells) was not as severe as in the thymus (Figure 2C). The
most likely explanation for this difference between the thymus and
periphery was the gradual accumulation of peripheral T cells in
the tge
Mut mice and expansion of their number as a result of
lymphopenia driven homeostasis.
To test this idea, we first examined the status of these T cells in
terms of proliferation. Tge
Mut and control mice were given
bromodeoxyuridine (BrdU) (0.8 mg/ml) in their drinking water for
9 consecutive days after which BrdU incorporation into CD4
+ and
CD8
+ T cells was assessed by flow cytometry (Figure 3B). Only
Table 1. Levels of TCR and CD3ec on the surface of immature or mature T cells from transgenic and C57BL/6 mice.
DP Thymocytes
a,b Naı ¨ve CD4
+ T Cells
b Naı ¨ve CD8
+ T Cells
b Total CD4
+ T Cells
b,c Total CD8
+ T Cells
b,c
Anti TCR-Cb
(H57–597)
d
Anti TCR-Cb
(H57–597)
d
Anti TCR-Cb
(H57–597)
d
Anti TCR-Cb
(H57–597)
d
Anti CD3ec
(7D6)
d
Anti TCR-Cb
(H57–597)
d
Anti CD3ec
(7D6)
d
tge
WT 100 100 100 100 100 100 100
tge
Mut 92.564.4 87.566.1 91.267.9 58.9613.7 72.465.6 72.8610.3 88.4615.0
C57BL/6 98.8 ND
e ND
e 133.1616.6 178.1 184.4629.6 212.2
aDP thymocytes were suspended and cultured in medium at 37uC for 4 h before analysis.
bValues are the geometric average of the mean fluorescence intensity (expressed as the percent of the value obtained with tge
WT cells) 6 SD.
cTotal CD4
+ or CD8
+ T cells were from peripheral spleen and lymph nodes.
dmAb used for flow cytometry.
e‘‘ND’’ refers to ‘‘not done.’’
doi:10.1371/journal.pbio.1000253.t001
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with the observations in normal mice in a previous study [30]. In
the tge
Mut mice, on the other hand, more T cells incorporated
BrdU, especially in the CD4
+ population. This indicated that more
peripheral T cells in the tge
Mut mice were actively proliferating,
probably due to homeostatic expansion.
WethenexaminedtheactivationstatusoftheseTcellsintermsof
surface markers, because it has been reported that naı ¨ve T cells
acquire a memory-like phenotype through lymphopenia-driven
proliferation [31–34]. As showed in Figure 3C and 3D, the control
mice had a substantial population of peripheral T cells with a naı ¨ve
phenotype (CD44
loCD62L
hi) and few T cells with a memory-like
phenotype (CD44
hiCD62L
lo). The opposite was seen in the tge
Mut
mice. Some T cells remained naı ¨ve, but many had acquired a
memory-like phenotype. Thus, the proliferative status and surface
phenotype of the peripheral T cells in the tge
Mut mice were
consistent with the presence of T cells that had gone lymphopenia-
induced homeostatic expansion. However, interestingly, this
expansion did not result in the full recovery of peripheral T cell
numbers in the tge
Mut mice (Figure 3A). Since TCR engagement by
self-MHC has been implicated in maintenance of the naı ¨ve T cell
population [35,36], it is possible that this TCR dependent process is
also impaired somewhat by the mutations in CD3e.
While homeostatic expansion most likely accounted for some of
the size of the peripheral CD4
+ and CD8
+ T cell population in the
tge
Mut mice, these cells were not oligoclonal. When tested with a
set of anti-Va and anti-Vb antibodies, all V elements were present
in the population, although the exact usage of particular Vaso r
Vbs was somewhat skewed (Figure S1). It is possible that this is a
consequence of combined effects by CD3e mutations on both
thymic output and homeostatic expansion.
The Cysteine Mutations Affect the CD4
+ and CD8
+
Population Unequally
In the tge
Mut mice, we noticed that the impact of the cysteine
mutations was more profound for the CD4
+ T cell population than
Figure 2. Transgenic mice with cysteine mutations have defects in T cell development in the thymus. (A) Total cell counts in various
organs in the combined wt control (Cntl, open bars) versus the mutant transgenic mice (tge
Mut, filled bars). Cell counts were obtained after the lysis of
red blood cells. Data from lymph nodes represent cell counts from inguinal, brachial, and axillary lymph nodes combined and are shown as the
number per lymph node. Data shown are for 8 tge
Mut mice and 13 wt control mice (4 BL6, 1 tge
WTcd3e
+/2,5t g e
Mutcd3e
+/2, and 3 tge
WT). (B) Total cell
counts in the thymus that were at the DN1, DN3, or DN4 stage. The stages are defined by CD44 and CD25 costaining, with a schematic view shown in
the upper-left corner of the graph. Data shown are for 8 tge
Mut mice (circles) and 13 wt control mice (squares) as in (A) and 2 cd3e
2/2 mice
(diamonds). (C) Number of thymocytes that were at the double positive (DP) or single positive stages (CD4 SP and CD8 SP) in control (open bars)
versus tge
Mut (filled bars) mice. The numbers of mice examined are as in (A). (D) The percentage of CD5
hi cells at the double positive stage of T cell
development in the thymuses of control (open bars) versus tge
Mut (filled bars) mice. The numbers of mice examined are as in (A). (E) The percentage
of CD69
hi cells at the double positive or single positive stages of T cell development in the thymuses of control (open bars) versus tge
Mut (filled bars)
mice. Data shown are for 4 tge
Mut mice and 8 wt control (cntl) mice (3 BL6, 1 tge
WTcd3e
+/2,1t g e
Mutcd3e
+/2, and 3 tge
WT). For (B–E) cells from the
thymus were costained with multiple antibodies against surface proteins (CD4, CD8, B220, CD44, CD25, CD5, and CD69). To avoid including non-T
lineage cells and minimize nonspecific staining, only live B220
2 cells were analyzed. The mean of the group and the SEM are indicated. p values were
obtained from t tests. In some cases, fold decreases are indicated.
doi:10.1371/journal.pbio.1000253.g002
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+ T cell population. This difference first appeared in
the thymus at the SP stage where the reduction in cell numbers
and the poor up-regulation of CD69 was much more striking for
CD4
+ than for CD8
+ SP cells (Figure 2C, E). It was also true for
peripheral T cells (Figure 3A and Figure 4). While, as mentioned
above, the overall reduction in peripheral SP T cells in the tge
Mut
mice was not as dramatic as in the thymus, the overall effect was
still greater for CD4
+ than for CD8
+ cells, leading to a significant
decrease in the CD4/CD8 ratio. This is probably partially due to
the unequal output of CD4
+ and CD8
+ T cells from the thymus,
but also might indicate a differential effect of the CD3e mutations
on TCR driven homeostatic expansion of the two populations.
TCR Signaling Is Compromised in Peripheral T Cells from
tge
Mut Mice
It was important to find out how well the TCRs on the tge
WT
and tge
Mut peripheral T cells signaled the cell following TCR
engagement. We used two flow cytometric measurements of TCR
signaling, cytoplasmic staining for the rapid, transient phosphor-
ylation of ERK1/2 [37] and surface staining for the induction of
CD69 [38]. In an initial experiment examining total CD4
+ or
CD8
+ T cells stimulated with an anti-Cb mAb, we found that the
tge
Mut T cells responded more poorly than the tge
WT T cells in
both assays (Figure S2). However, since we subsequently found
that the mutant mice had a large population of homeostatically
expanded T cells, which had no direct counterpart in the tge
WT
mice, we examined the mice again, confining the analyses to those
T cells that had a naı ¨ve phenotype (Figure 5). After activation by
TCR cross-linking with the anti-Cb mAb for 20 min, fewer CD4
+
and CD8
+ naı ¨ve T cells from the tge
Mut mice had phosphorylated
ERK than from the tge
WT mice (Figure 5A). This is true even at
various levels of TCR occupancy by the antibody. Likewise, after
activation by TCR cross-linking with the anti-Cb mAb for 12 h,
fewer CD4
+ and CD8
+ naı ¨ve T cells from the tge
Mut mice had up-
Figure 3. The numbers of mature T cells from transgenic mice bearing mutated CD3e were decreased, and they were actively
proliferating in a homeostatic manner. In all panels data for control mice are open bars and for tge
Mut mice are filled bars. (A) The cell counts of
mature CD4
+ or CD8
+ T cells in the spleen. Fold decreases for the two populations are indicated. Data shown are for 8 tge
Mut mice and 13 wt control
mice (4 BL6, 1 tge
WTcd3e
+/2,5t g e
Mutcd3e
+/2, and 3 tge
WT). (B) The incorporation of BrdU into the mature T cells. Mice were given drinking water
containing 0.8 mg/ml BrdU for 9 consecutive days before sacrifice. Data shown are three mice for each group. (C, D) The percentage of
CD44
hiCD62L
lo or CD44
loCD62L
hi T cells in the CD4
+ or CD8
+ population of spleen and lymph nodes. The numbers of mice examined are as in (A).
Spleen or pooled lymph node (inguinal, brachial, and axillary) cells were costained with antibodies against B220, CD4, CD8, CD44, CD62L, as well as
BrdU in the case of (B). The percentages were obtained from flow cytometry data by gating on live B220
2CD4
+ or B220
2CD8
+ cells. Data are shown as
the mean 6 SEM. p values were obtained from t tests.
doi:10.1371/journal.pbio.1000253.g003
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WT mice (Figure 5B). These
results established that the TCR complex containing the mutant
CD3e transduced an activation signal into the T cell less efficiently
than TCR complexes containing wt CD3e, despite using a high
affinity anti-TCR mAb to cross-link the TCRs on the cell surface.
To see how signaling would be affected by an antigen of much
lower affinity presented by MHCII on antigen presenting cells
(APCs), we then stimulated the T cells with the bacterial
superantigen, SEB. This enterotoxin binds to MHCII on APCs
and is recognized by nearly all T cells whose TCRs bear members
of the Vb8 family [39]. The affinities of the enterotoxin
superantigens for TCRs bearing the appropriate Vbs fall within
the range of affinities seen for conventional peptide-MHC
complexes, i.e. KDs in the 1 to 100 uM range [40]. Therefore,
spleen and lymph node cells from the tge
WT or tge
Mut mice were
incubated with an optimal concentration of SEB for 15 h. The up-
regulation of CD69 on the surface of naı ¨ve CD4
+ or CD8
+ T cells
was assessed (Figure 5C). As seen with the anti-Cb mAb, fewer
naı ¨ve T cells from the tge
Mut mice than from the tge
WT mice up-
regulated CD69 in response to SEB. As a negative control, we
examined in the same cultures SEB-nonreactive T cells bearing
Vb6. In this case very few cells from either mouse had up-
regulated CD69. Thus, whether we engaged the TCR by a high
affinity anti-Cb mAb or a low affinity MHCII presented
superantigen, the mutant TCR complex signaled poorly compared
to the wt complex.
Finally, although the TCR containing the mutant CD3e
appeared to be assembled normally, as judged by staining with
various anti-TCR and anti-CD3 mAbs (Table 1), one possibility
was that a subtle structural defect had disturbed the interface
between CD3e and Cb and/or Ca, which interrupted the
transduction of a ‘‘recognition’’ signal from the TCR ab to the
CD3 complex. To test this idea we used an anti-CD3e mAb to
directly cross-link the receptor complex while bypassing the
abTCR chains. Generation of pERK was compared in naı ¨ve
CD4
+ T cells from tge
WT and tge
Mut mice at 20 min after cross-
linking the TCR complex with either an anti-Cb or anti-CD3e
mAb. As showed in Figure 5D, regardless of the cross-linking
antibody, fewer T cells from the tge
Mut mice than from the tge
WT
mice had pERK. These data strongly suggest that the defect in
signaling in the tge
Mut T cells was intrinsic to the CD3e molecule
rather than due to the disruption of its interaction with TCR
constant regions.
We conclude from these experiments that TCRs containing the
mutant CD3e, while apparently fully assembled, fail to transduce a
fully effective signal across the T cell membrane when engaged via
either the ab or CD3 portion of the TCR complex. This signaling
defect is intrinsic to the mutant CD3e molecule, seen over a wide
range of TCR occupancies with various activating signals.
Discussion
The function of the conserved CXXC motif in the stalk region
of the CD3 c, d, and e has been under debate for over a decade.
Numerous studies have been performed in vitro to understand the
effect on TCR complex assembly of mutation of these cysteines.
Some have suggested that the CXXC motif is involved in the
dimerization of CD3e to CD3c or to CD3d [21,23]. Others
[20,22], however, did not find significant impairment of assembly
either of CD3 dimers or of the complete TCR complex by
mutating those cysteines in CD3e alone. In preliminary experi-
ments for our studies reported here, we tested our Cys to Ser
mutated CD3e construct for expression in T cell hybridomas that
also had endogenous CD3e. We found that, while the mutant
protein could incorporate into the surface TCR complex, it
competed poorly against the endogenous CD3e during the process
(Figure S3).
Nevertheless, as shown in Table 1, in our tge
Mut mice, in the
absence of competing endogenous CD3e, the mutated CD3e
incorporated well enough into the TCR complex to rescue surface
TCR expression to a level virtually the same as seen with the non-
mutated CD3e. Moreover, the association of mutated CD3e with
CD3c appeared normal, at least as judged by reactivity with an
antibody specific for the associated CD3c/e heterodimer (Table 1).
Therefore, this transgenic mouse offered us a unique opportunity
to study the function of these cysteines in TCR signaling
independent of their role in TCR complex assembly. Our results
showed that all TCR-dependent developmental stages of T cells
were partially impaired in the tge
Mut mice.
The chemical nature of these cysteines in the CD3 molecules is
still not known unequivocally. Extracellularly exposed, unprotect-
ed cysteines are not common in proteins because they are too
reactive to be maintained in a reduced state in the oxidative
environment outside the cell. Therefore, several other structural
possibilities have been considered for these cysteines. One
suggestion was that they were involved in the formation of
disulfide bonds to other proteins, e.g. cross-linking CD3 molecules.
However, with a few exceptions [23,41], there is very little
evidence to support this idea. Another suggestion has been that the
cysteines on adjacent CD3 molecules are involved in tetra-
Figure 4. The cysteine mutations affected the CD4
+ and CD8
+
population unequally. Spleen cells from control (4 BL6, 1
tge
WTcd3e
+/2,5t g e
Mutcd3e
+/2, and 3 tge
WT, open circles) or tge
Mut
(filled diamonds) mice were costained using anti-B220, anti-CD4, and
anti-CD8 antibodies. The CD4 to CD8 ratio was calculated based on live
B220
2CD4
+ or the B220
2CD8
+ cells. p values were obtained using t
tests.
doi:10.1371/journal.pbio.1000253.g004
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nature. However, Borroto et al. [23] and Xu et al. [20] used
chelation reagents during TCR complex assembly and did not see
any effect, arguing against this idea. In addition, Xu et al. found
that mutating single cysteine residues in the CXXC motif led to
covalently linked CD3 dimers, suggesting that the two adjacent
cysteines were protected very early in the TCR assembly process.
Perhaps the most favored hypothesis is that within the CD3
CXXC motif a short intramolecular disulfide bond forms.
Whatever the actual structural form of these CXXC motifs is,
our results suggest that they give some important structural
conformation to the bundle of stalks of the four CD3 molecules. In
the most widely reported structure of the TCR complex, this
bundle includes 2e,1 c, and 1d CD3 chains, all of which are
required for optimal transmission of a signal from the ligand
portion of the TCR complex to the interior of the T cell.
The mechanism of TCR complex signaling has been intensely
studied over many years. Much has been learned about the
downstream pathways activated by TCR engagement, yet a final
consensus has not been reached on how engagement of the TCR
creates a signal that crosses the cell membrane to initiate the
downstream signaling events. Some of the proposed mechanisms
are shown schematically in Figure 6A.
The longest standing hypothesis has been a simple aggregation
model, originally well laid out by Fewtrell and Metzger [42] to
explain IgE Fc receptor signaling and subsequently thought to play
a role in many other receptor systems, including the abTCR.
According to this model, in T cells the proteins that initiate the
signal are already associated with the cytoplasmic tails of the CD3
proteins, f, and the CD4/CD8 co-receptors. However, these
proteins do not have access to one another until these molecules
coalesce to form clusters, at the interface between the T cell and
the APC [10,11,43]. Once aggregated, interactions such as cross-
phosphorylation among the associated signaling molecules attract
other proteins to propagate the signal cascade.
An alternate hypothesis has been that engagement of individual
TCRs creates an intrinsic allosteric signal that transverses the T
cell membrane to induce a conformational change in the CD3
Figure 5. TCR signaling is compromised in the naı ¨ve peripheral T cells from tge
Mut mice. (A) ERK1/2 phosphorylation versus TCR
occupancy in naı ¨ve CD4
+ or naı ¨ve CD8
+ T cells. As described in Materials and Methods, T cells from spleen and lymph nodes of tge
WT (open circles) or
tge
Mut (filled circles) mice were nylon wool-purified and activated for 20 min with various concentrations of anti-Cb antibody. The percentage of
naı ¨ve (CD44
lo) CD4
+ and CD8
+ T cells containing pERK was determined. The data are presented as the percent of pERK
+ cells versus the amount of
anti-Cb antibody bound (geometric mean fluorescence intensities, M.F.I.). The values of pERK
+ were from the CD44
loCD4
+ or CD44
loCD8
+ populations,
hence the ‘‘naı ¨ve CD4
+’’ or ‘‘naı ¨ve CD8
+’’. In each experiment, cells of each group were pooled from two individual animals. (B) CD69 induction on
naı ¨ve (CD44
lo) CD4
+ or CD8
+ T cells from tge
WT (open bars) or tge
Mut (filled bars) mice after T cell activation. Nylon wool-purified T cells were
stimulated with nothing, plate-bound anti-TCR-Cb (H57–597) antibody or 20 nM PMA for 12 h. Surface induction of CD69 was assessed by flow
cytometry. Data are shown as the mean 6 SD for three independent experiments. p values are from t test. (C) Naı ¨ve T cells from the tge
Mut mice
respond poorly to superantigen stimulation. Spleen and lymph node cells from tge
WT (open bars) or tge
Mut (filled bars) mice were cultured with SEB
(10 mg/ml) for 15 h. The induction of CD69 on CD4
+ and CD8
+ naı ¨ve T cells bearing either Vb8 (SEB-reactive) or Vb6 (SEB-non-reactive) T cells was
determined by flow cytometry. The data are expressed as the average increase in cells expressing CD69 (%) over that observed in control cultures
that received no SEB. (D) The defect in signaling in the tge
Mut T cells was intrinsic to the CD3e molecule. Nylon wool-purified T cells from tge
WT (open
bars) or tge
Mut (filled bars) mice were stimulated by plate-bound anti-TCR-Cb or anti-CD3e antibodies at 37uC for 20 min. After stimulation, CD4
+ T
cells were analyzed for intracellular pERK by flow cytometry. The dash line indicates the control cells that were not stimulated by the antibodies. Data
(circles) are from two independent experiments. In each experiment, cells of each group were pooled from two individual animals.
doi:10.1371/journal.pbio.1000253.g005
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considered. One is the classic intramolecular transmission of
conformational change such as seen in the regulation of many
enzymes. In this case the binding of the TCR to the MHC/
peptide ligand creates a conformational change that is transmitted
through the TCR V and C domains to the Ig-like domains, stalks
and transmembrane domain of the CD3 molecules leading to a
conformational change in the CD3 cytoplasmic tails. Alternately,
the allosteric signal could be transmitted mechanically, such as
seen with the bacterial aspartate receptor [44]. In this case either
translational or torsional forces generated by binding of the APC
anchored MHC/peptide to the T cell anchored TCR complex
ultimately distorts the CD3 cytoplasmic tails. In either case, the
essential points are that the final cytoplasmic conformational
change creates a site that attracts the initiating protein to the TCR
complex and that each TCR has the potential to initiate some type
of signal independent of aggregation [12,14,16].
Evidence for and against these models has accumulated over the
years. The strongest evidence for the aggregation hypothesis has
been that, in general, monovalent ligands in solution are
ineffective in inducing TCR activation, whereas a wide variety
of immobilized or soluble polyvalent ligands (multimerized anti-
Vb, anti-Cb, and anti-CD3e monoclonal antibodies, MHC
presented bacterial and viral superantigens and, of course, specific
MHC/peptide on APCs) all efficiently activate T cells. Further-
more, many microscopy studies have confirmed the presence of
aggregated TCR complexes in activation clusters that form at the
interface between T cells and APCs [8,10,11,43,45]. Recently,
some studies have suggested that the minimal signaling unit on a T
cell may be a cluster of just two TCR complexes [46,47].
However, other data have been difficult to explain by a simple
aggregation model and have led to proposals for some type of
allosteric signaling. Initially, this idea arose from the demonstra-
tion that some anti-TCR antibodies and ‘‘altered peptide ligands’’
activated T cells poorly despite apparently reasonable TCR
binding (reviewed in [17]). More recently, more direct evidence
has been reported showing that the TCR engagement leads to the
exposure of a proline-rich sequence (PRS) in the cytoplasmic tail of
CD3e, which then recruits the ubiquitously expressed adaptor
protein Nck [14,16]. This rapid change can happen at 0uC in the
apparent absence of aggregation and is independent of any
tyrosine kinase activity. The physiological importance of the PRS
region, however, is still under debate. An earlier study showed that
the mice without PRS region had normal T cell development and
function [48]. A more recent study done by Mingueneau et al.
[49], however, found that although the mature TCR transgenic T
cells carrying the deletion of the PRS region responded to MHC/
peptide normally, the DP thymocytes in such mice had up-
regulated surface expression of the TCR complex. The study also
showed that the PRS region enhanced TCR sensitivity to weak
MHC/peptide ligands.
How such an allosteric signal might cross the membrane is still
unknown. In one analysis of crystallographic data comparing
TCRs in a bound versus free state, conformational adjustments at
the interface between TCR and MHC/peptide were common, but
there were no obvious conformational changes in Ca and Cb
regions upon ligand binding, with one exception (reviewed in
[50]). However, more recently a similar analysis has concluded
that there is a conformational change in Ca upon TCR
engagement that is required for effective signal transduction
[51], consistent with the idea of a direct intramolecular allosteric
signal. Alternatively, several recent studies have argued for
mechanical allosteric TCR signaling. For example, Sun et al.
have suggested a piston-like signaling mechanism for the TCR, in
Figure 6. Implications of effects of the CD3e mutation on models of TCR signal transduction. (A) Schematic representation of proposed
models for signal transduction across the T cell membrane to initiate downstream signaling. For simplicity the f chain and CD4/CD8 co-receptors are
omitted from the diagrams. ‘‘I’’ denotes the critical protein required for initiation of the signaling pathway. See text for discussion. (B) Predicted effect
of the CD3e mutation on the various models. See text for discussion.
doi:10.1371/journal.pbio.1000253.g006
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complex pulling on the CD3 transmembrane regions changing
their membrane proximal intracellular conformation [22]. Others
have suggested a ligand induced mechanical displacement and/or
reorientation of the CD3 heterodimers within the TCR complex
[13,18,52]. A study done by Ma et al. [12] has suggested that such
a mechanical force is generated by the TCR pulling away from
MHC/peptide during the T cell/APC interaction.
Allosteric and aggregation mechanisms are not mutually
exclusive and it may be that both contribute to the efficiency of
TCR signaling. For example, Minguet et al. [18] have concluded
that both TCR aggregation and exposure of the cytoplasmic Nck
binding site were required for optimal T cell activation. They
propose a new model of TCR activation called permissive
geometry, in which the role of aggregation and conformational
change are combined [53]. In this model, the existence of MHC/
peptide dimers or multimers is required, because this leads to a
reorientation of the subunits (TCRa, b, and CD3 e, d, and c)
within the TCR complex that is required for a full TCR
activation.
Our results with mutated CD3e argue against a simple
aggregation model for TCR signaling (Figure 6B), since if bringing
multiple CD3 cytoplasmic tails into close proximity were sufficient
for signaling, we would not expect our finding of compromised
signaling via the tge
mut TCR even after very strong TCR cross-
linking with a high affinity anti-Cb or anti-CD3e mAb. However,
we cannot rule out that CXXC motif might still play a role in the
correct orientation of the CD3e cytoplasmic tails during
aggregation.
Our ability to test allostery models via direct biochemical or cell
biological approaches in our mice were limited by the small
number of naı ¨ve mutant T cells we can isolate from our mice, e.g.
not enough to perform Nck binding experiments ala the Alarco ´n
group [16]. However, we wanted to attempt some experiments to
relate our results to those of this group. Therefore, we have tried
the alternate approach of cytoplasmic staining with the APA1.1
Mab, since the Alarco ´n group has reported that this Mab binds to
the PRS on the CD3e cytoplasmic tail, which is exposed only after
TCR triggering [19]. We cytoplasmically stained our wt and
mutant naı ¨ve T cells with APA1.1 before and after maximal TCR
cross-linking. All four of the T cell populations stained well with
the antibody, but unfortunately there were no differences in the
staining patterns before and after stimulation, nor any difference
between the wt and mutant T cells (unpublished data). Thus, we
found that the APA1.1 binding site appeared fully exposed before
activation with either type of cell. The reasons for the differences
between our results and those of the Alarco ´n group are not
apparent. The answer may lie in the different cell types (e.g.
human Jurkat tumor cells or COS cells versus normal mouse T
cells). However, even though our experiments have not yet tested
directly any of the alternative allostery models, one could
nevertheless predict that disrupting the rigidity or stability of the
CD3e stalk region by mutation of the cysteines in the CXXC motif
might interrupt the transmission of either type of allosteric signal
through the stalks to the transmembrane regions (Figure 6B).
The most dramatic effect of the CD3e mutation during T cell
development in the transgenic mice was a severe bottleneck in the
thymus at DN to DP transition, a process driven by the pre-TCR,
in which the pre-TCR alpha (pTa) chain that lacks a V-region
replaces the TCR chain. The molecular mechanisms of signals
transmitted through the pre-TCR are not fully understood. CD3e
is an essential component of this receptor [24,25], which is thought
to signal constitutively without the need of a ligand [7]. A recent
study done by Yamasaki et al. [54] showed that the pre-TCR
complex can spontaneously form oligomers. Also, when the
authors created a pre-formed chimeric dimer by fusing the trans-
membrane and extracellular regions of CD8 to the cytoplasmic
region of CD3e, they found that this molecule was sufficient
to promote pre-TCR signaling, but did not activate peripheral
T cells.
These results could mean that aggregation is all that is required
for pre-TCR signaling and that the extracellular regions of the
receptor components may be important for surface expression, but
not for signaling. If this were the case, the drastic reduction in pre-
T receptor mediated differentiation in our mutant mice could be
due to poor incorporation of the mutant CD3e into the pre-TCR
complex, rather than an essential role for the CXXC motif in
signal transduction. Unfortunately, we have not been able to
answer this question, since the pre-TCR is normally expressed at
very low levels and we have not yet succeeded in comparing
quantitatively its surface expression on DN3 thymocytes from
tge
WT to tge
Mut mice.
The effect of mutating the CXXC motif in CD3e was much
more dramatic on the thymic development of CD4
+ T cells than of
CD8
+ T cells. The ‘‘instructive model’’ of CD4-CD8 lineage
commitment in the thymus (reviewed in [55]) proposes that the
signal strength/intensity initiated by the TCR-ligand interaction is
one of the important ‘‘instructors’’ that determines the CD4/CD8
fate of a DP thymocyte. Thus, if a weak signal defaults the cell to
the CD8 pathway, it is possible that the thymocytes with mutated
CD3e preferentially differentiated into CD8
+ T cells, including
those that would have normally differentiated into CD4
+ T cells.
This might also explain the changed Vb and Va repertoire in the
periphery (Figure S1).
Finally, our studies point to the stalk region of CD3e as
important for TCR signal transduction, complementing the
studies of Naeher et al. [56] on the importance of the stalk region
connecting TCR Ca to its transmembrane region in T cell
development and function. These results raise the question of
whether in the fully assembled TCR complex the four CXXC
containing stalks of the CD3 proteins (1c,1 d, and 2e) combine
with the TCR a and b stalk peptides to form a stable bundle that is
essential for proper TCR signaling. Solving the atomic details of
this complex has so far eluded structural biologists.
Materials and Methods
Animals
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the National
Jewish Health Animal Care and Use Committee–Protocol N.
AS2517.
C57BL/6J (BL6) mice were obtained from The Jackson
Laboratory. cd3e
2/2 mice, which were originally obtained from
The Jackson Laboratory as B6;129-CD3e
tm1Lov/J mice [24], were
backcrossed for more than seven generations to the BL6 strain and
bred at National Jewish Health animal facility. Transgenic mice
bearing the non-mutated stalk region of CD3e (e
WT) or a variant
with two C to S mutations (e
Mut) were generated in the same
facility. Briefly, cd3e cDNA was obtained using RT-PCRs from
the splenocyte mRNA of normal BL6 mice. A multi-step PCR was
performed to add a human c-Myc tag sequence ‘‘EQKLISEEDL’’
between the N terminus and signal peptide with a linker ‘‘GGGS’’
sequence and a flash tag sequence ‘‘CCPGCC’’ to the C terminus
of CD3e (Figure 1B). PCR products were cloned between two
EcoRI restriction sites using a pCRII-TOPO TA cloning kit
(TOPO TA CloningH, Invitrogen). Point mutations then were
CD3e Conserved Cysteines Control TCR Signaling
PLoS Biology | www.plosbiology.org 9 December 2009 | Volume 7 | Issue 12 | e1000253introduced using PCRs (QuikChange II, Stratagene) to create
mutated stalk regions carrying serines in place of the cysteines. All
subcloned constructs were confirmed by sequencing. Then,
nonmutated and mutated sequences were separately introduced
into an improved human CD2 minigene cassette [57] using the
EcoRI sites. Founder mice were generated by standard transgenic
procedure using BL6 embryos. For each line, at least two founder
mice were identified and crossed to cd3e
2/2 mice to provide F2
progeny. Those with a transgenic and endogenous cd3e
2/2
genotype (tge
Mut or WTcd3e
2/2, abbreviated as tge
Mut or tge
WT)
were monitored by cell surface expression of c-Myc (see Flow
Cytometry for details) and competitive PCR assays.
Primers
All primers were synthesized in the Molecular Resource Center
of the National Jewish Medical and Research Center. Primers
used for mutating the two conserved cysteines in the stalk region of
mouse CD3e were as follows: 59-CTGAAAGCTCGAGTGTCC-
GAGTACTCCGTGGAGGTGGACC-39 (forward primer) and
59-GGTCCACCTCCACGGAGTACTCGGACACTCGAGCT-
TTCAG-39 (reverse primer). Primers used for determining the
presence of the endogenous cd3e gene were as follows: 59-
TACAAAGTCTCCATCTCAGG-39 (forward primer), 59-
CTCCTATTGTCTATTGTGATGC-39 (reverse primer), and
59-GACTGAATCTGTTTACTACTGAG-39 (reverse primers).
Antibodies
Anti-BrdU (Alexa Fluor 647 conjugated) antibodies were
purchased from Invitrogen. Rabbit anti phospho-ERK antibodies
were purchased from Cell Signaling Technology. Donkey anti
rabbit antibodies (Alexa Fluor 647 conjugated IgG) were
purchased from Invitrogen. Antibodies against B220 (Pacific
Blue-conjugated RA3-6B2) were purchased from eBioscience.
Antibodies against CD4 (APC-Cy7-conjugated L3T4), CD5
(FITC- or PE-conjugated 53–7.3), CD8a (APC- or PerCp-
conjugated 53–6.7), CD25 (PE- or PE-Cy7-conjugated PC61),
CD62L (PE- or PE-Cy7-conjugated MEL-14), CD69 (PE-
conjugated H1.2F3), and Thy1.2 (FITC-conjugated 53–2.1) were
purchased from BD Pharmingen. Antibodies against CD3e
(unconjugated or FITC-conjugated 145-2C11), CD44 (Alexa
Fluor 488-conjugated IM7), c-Myc (biotin-conjugated 9E10),
mouse Fc receptor (24G2), and TCR-Cb (Alexa Fluor 647 or
biotin-conjugated H57–597) were purified and/or coupled to the
fluorochromes or biotin using standard methods in the Kappler/
Marrack lab at the National Jewish Health.
Flow Cytometry
Cell suspensions of mouse tail blood, spleen, lymph nodes
(inguinal, brachial, and axillary), and thymus were prepared
according to standard protocols, and stained with fluorescent or
primary antibodies in BSS wash buffer (balanced salt solution with
0.5% FBS and 0.1% sodium azide) containing at least 20% 24G2 to
block non-specific staining by Fc receptor. In some cases, cells were
further stained with the appropriate secondary antibodies or APC-
conjugated streptavidin, as described for the primary antibodies.
Analytical flow cytometry was performed with a Cyan flow
cytometer (Dako Cytomation) and data were analyzed using
FlowJo software (Tree Star, Inc.). Only live cells determined by
forward and side scatter were used for analysis. A B220 dump
channel was also included in some of the experiments to exclude
nonspecific signals from other populations of cells (B cells,
macrophage, etc.) found in the spleen, lymph nodes, and thymus
of the transgenic mice.
To screen mice that expressed the transgenes, peripheral blood
leukocytes were co-stained with antibodies against Thy1.2 and c-
Myc. The live cells were first gated based on Thy1.2 expression.
The Thy1.2
+ population from the transgenic mice was then
overlaid with the population from a BL6 mouse in terms of c-Myc
staining (Figure S4). Only those mice with at least 2-fold increases
of c-Myc staining were further analyzed.
BrdU Incorporation Assay
For analysis of cell homeostatic proliferation using BrdU, mice
were given drinking water containing 0.8 mg/ml BrdU (freshly
made each day) for 9 consecutive days before sacrifice as
previously described [30]. Cell preparation was carried out as
described previously [58]. Finally, cells were stained with Alexa
Fluor 647-coupled anti-BrdU antibodies on ice for 30 min,
washed, and resuspended in PBS wash buffer for flow cytometry
analysis.
TCR Cross-Linking and T Cell Activation Assays
The day before the experiment, the wells of a 96-well flat
bottom plate were coated with 1) mAbs against TCR-Cb (H57-
597) at a concentration of 10 mg/well, 2) mAbs against CD3e
(145-2C11) at a concentration of 10 mg/well, or 3) ExtrAvidin
(Sigma) at a concentration of 7.5 mg/well at 4uC overnight. The
next day, the plate was washed and blocked with CTM (complete
tumor medium, MEM enriched with essential and nonessential
amino acids, glutamine, sodium bicarbonate, 10% fetal bovine
serum, and 20 mM 2-mercaptoethanol) at room temperature until
it was used.
To generate samples whose TCRs were occupied with a
different amount of anti Cb mAbs, T cells from nylon wool-
purified spleen and lymph nodes cells were first seeded in duplicate
in the wells of another uncoated 96-well plate at 1 million cells per
well. They were then incubated with a biotin-conjugated anti-
TCR Cb mAb (H57–597) at various concentrations, in the
presence of the anti-Fc receptor Mab, 24G2, on ice for 30 min.
After the treatment, unbound antibodies were washed away. One
of the duplicates was stained with APC-conjugated streptavidin
(BD Pharmingen) and analyzed using flow cytometry to determine
the level of TCR occupancy. The other duplicate was transferred
on ice to the wells of ExtrAvidin-coated plate at a final
concentration of less than 2.5610
5 cells/well for receptor cross-
linking.
Alternatively, nylon wool-purified T cells were directly seeded in
the plates coated with mAbs. All types of transferred cells were
then briefly spun down to the bottom (5006ga t0 uC for 2 min) to
achieve rapid and maximal activation, and incubated at 37uC with
CO2 for various time points. In some experiments, total
splenocytes were seeded in an untreated plate at 5610
6 cells/
well and incubated with SEB at a final concentration of 10 mg/ml
in CTM.
For studying intracellularly phosphorylated ERK, after 20 min
stimulation, paraformaldehyde (Sigma) solution was added to the
wells at a final concentration of 2% to stop the reaction. The
phospho-ERK staining was then performed according to the
manufacturer’s protocol. The samples were then stained with
Alexa Fluor 647-coupled anti-rabbit antibodies, and were then
analyzed using flow cytometry.
For studying induced surface CD69, cells after at least 8 h
stimulation were harvested and washed in BSS wash buffer.
Samples then were stained with antibodies against CD69 as well as
other surface markers, including B220, CD4, CD8, CD44, and
TCR-Vbs, according to routine protocol for multi-color flow
cytometry.
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Graphs of numerical data and statistics were generated using
Prism 4 program (GraphPad Software, Inc.).
Online Supplemental Material
Four figures are included in the supplemental material. Figure
S1 compares the Va and Vb repertoires in the tge
Mut and tge
WT
mice. Figure S2 shows the differences in pERK and CD69
induction in total peripheral T cells from tge
Mut and tge
Wt mice
after TCR cross-linking. Figure S3 shows the competition in a T
cell hybridoma between endogenous and transduced CD3e for
incorporation into the surface expressed TCR complex. Figure S4
shows the histograms of surface expressions of CD3e transgenes in
the backcrossed endogenous-cd3e-null transgenic mice (tge
WT or
tge
Mut) by staining c-Myc tag on the cell surface.
Supporting Information
Figure S1 Transgenic mice bearing cysteine-mutated
CD3e had a changed but not oligoclonal T cell repertoire.
Va usage in CD4
+ (A) or CD8
+ (B), and Vb usage in CD4
+ (C) or
CD8
+ (D) T cells were determined by flow cytometry. Cells from
spleens were costained with anti-B220, anti-CD4, anti-CD8, and
different anti-TCR V segment antibodies. The use of different V
chains was calculated by gating on the CD4
+ or CD8
+ cells from the
alive and B220- population. ‘‘Cntl’’ refers to combined wt control
mice as described in Figure 2. Data shown are for 4 tge
Mut mice and
7 wt control mice (3 BL6, 3 tge
Mutcd3e
+/2,a n d1t g e
WT). Data are
indicated as the mean 6 SEM. p values were obtained from t tests.
Found at: doi:10.1371/journal.pbio.1000253.s001 (0.16 MB PDF)
Figure S2 Peripheral total T cells from tgeMut mice did
not respond properly after cross-linking the TCRs. (A, B)
Curves for phospho-ERK1/2 against the degree of TCR
occupancy in total CD4
+ or CD8
+ T cell populations. T cells
were from nylon wool-purified spleen and lymph node (inguinal,
brachial, and axillary) cells. The data were acquired as described
in Figure 5C, except total CD4
+ or CD8
+ T cells were assessed.
The data represent two independent experiments. In each
experiment, cells of each group were pooled from two individual
animals. (C) CD69 induction on total spleen T cells after TCR
cross-linking. Splenocytes from different mice were stimulated by
plate-bound anti-TCRb and anti-CD28 antibodies at 37uC for
17 h. After the stimulation, cells were harvested and CD69
induction was determined by flow cytometry. Data shown are for 2
tge
Mut mice and 5 wt control mice (1 BL6, 1 tgeWTcd3e+/2,1
tgeMutcd3e+/2, and 2 tge
WT). ‘‘Cntl’’ refers to the combined wt
control mice as described in Figure 2. The data are shown as the
mean 6 SEM. The p value was obtained from a t test. The data
represent two independent experiments.
Found at: doi:10.1371/journal.pbio.1000253.s002 (0.04 MB PDF)
Figure S3 Various expression levels of the mutant and
wt proteins from CD3e constructs were detected on the
cell surface, which was not due to the variation in
transduction or protein translation. (A) Histograms of GFP
or c-Myc staining from vector only (MiG, grey filled), c-Myc
tagged wt CD3e (e
WT, solid line), or mutated CD3e (e
Mut, dashed
line) retrovirally-transduced T hybridoma cells. DNA fragments of
non-mutated or mutated CD3e with tag sequences (Figure 1B)
were cloned into a mouse MSCV retrovirus expression vector
which independently expressed GFP (MiG). The constructs were
used to transduce B3K0508 T hybridoma cells. Transduced cells
were first sorted based on GFP expression. GFP-positive cells were
then cultured after sorting and stained with antibodies against the
c-Myc tag. The left panel is the overlay of GFP levels gated from
live cells. The right panel is the overlay of c-Myc levels gated from
both live and GFP-positive cells. (B) Western blots of the whole cell
lysates from CD3e transduced hybridoma cells. Various B3K0508
cells (2 million each) that were transduced with different CD3e
constructs were directly lysed in SDS-PAGE buffer. Samples were
immunoblotted with anti-CD3e antibodies. ‘‘CD3e-Trans’’ refers
to transduced CD3e proteins. ‘‘CD3e-Endo’’ refers to endogenous
CD3e proteins. The result is representative of more than three
independent experiments.
Found at: doi:10.1371/journal.pbio.1000253.s003 (0.05 MB PDF)
Figure S4 Histograms of staining for c-Myc expressed
on the cell surface from the endogenous-CD3e-null
transgenic mice (tge
WT or tge
Mut). PBLs from individual
mice with these genotypes were costained with anti-Thy 1.2 and
anti-c-Myc antibodies. The Thy1.2+ population from the
transgenic mice (red line) was overlaid with the Thy1.2
+
population from a BL6 mouse (grey filled). The mean fluorescent
intensity (MFI) values are indicated.
Found at: doi:10.1371/journal.pbio.1000253.s004 (0.03 MB PDF)
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